Simplex Trading’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Simplex Trading’s Portfolio CALT Stock Details CALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,400	Closed	-$15K	–	9960
2024 Q3	$15K	Sell	2,400 -100	-4%	-$3.94K	﹤0.01%	6930
2024 Q2	$97K	Buy	2,500 +2,300	+1,150%	+$63.2K	﹤0.01%	5415
2024 Q1	$4K	Sell	200 -900	-82%	-$20K	﹤0.01%	8192
2023 Q4	$28K	Buy	1,100 +100	+10%	+$1.87K	﹤0.01%	6643
2023 Q3	$18K	Sell	1,000 -300	-23%	-$5.19K	﹤0.01%	6737
2023 Q2	$20K	Buy	1,300 +1,000	+333%	+$21.1K	﹤0.01%	6799
2023 Q1	$7K	Sell	300 -1,600	-84%	-$32K	﹤0.01%	7866
2022 Q4	$32K	Buy	1,900 +1,000	+111%	+$16.1K	﹤0.01%	6404
2022 Q3	$13K	Buy	+900	New	+$15.7K	﹤0.01%	8022
2022 Q1	–	Sell	-1,300	Closed	-$32K	–	11624
2021 Q4	$32K	Buy	+1,300	New	+$26.1K	﹤0.01%	7829

Simplex Trading's CALT Position: Q4 2024 in Review

Simplex Trading sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q4 2024, closing a stake of 1,826 shares.

Simplex Trading first reported a position in CALT in Q4 2021 and held it in 9 quarters. The position peaked at $29K in Q4 2021. 0 funds tracked by Wall St. Rank hold CALT as of Q4 2024.

Simplex Trading reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q4 2024 after selling out during the quarter.
Simplex Trading sold 1,826 Calliditas Therapeutics AB American Depositary Shares shares in Q4 2024.
Simplex Trading first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q4 2021 and held it in 9 quarters.
Simplex Trading's Calliditas Therapeutics AB American Depositary Shares position peaked at $29K in Q4 2021.
0 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.